Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Iovance Biotherapeutics, Inc..
Iovance Biotherapeutics, Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Iovance Biotherapeutics, Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Iovance Biotherapeutics, Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Iovance Biotherapeutics, Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Iovance Biotherapeutics, Inc. and all latest updates of the company are provided.
The 2025 version of Iovance Biotherapeutics, Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Iovance Biotherapeutics, Inc.- Key Facts
2.2 Iovance Biotherapeutics, Inc.- Geographic Locations
2.3 Iovance Biotherapeutics, Inc.- Subsidiaries and Affiliates
2.4 Iovance Biotherapeutics, Inc.- Business Divisions
2.5 Iovance Biotherapeutics, Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Iovance Biotherapeutics, Inc. Strategic Analysis Review
3.1 Iovance Biotherapeutics, Inc.- Key Strategies
3.2 Iovance Biotherapeutics, Inc.- Company Outlook Statement
3.3 Iovance Biotherapeutics, Inc.- SWOT Analysis
3.3.1 Iovance Biotherapeutics, Inc.- Key Strengths
3.3.2 Iovance Biotherapeutics, Inc.- Key Weaknesses
3.3.3 Iovance Biotherapeutics, Inc.- Potential Opportunities
3.3.4 Iovance Biotherapeutics, Inc.- Potential Threats
3.4 Iovance Biotherapeutics, Inc.- Key Competitors
4. Business Description of the Company
4.1 Iovance Biotherapeutics, Inc.- Business Overview
4.2 Iovance Biotherapeutics, Inc.- Operations by Segment
5 Products and Services Details
5.1 Iovance Biotherapeutics, Inc.- Key Products
5.2 Iovance Biotherapeutics, Inc.- Key Service Areas
5.3 Iovance Biotherapeutics, Inc.- Key Brands
6 Company Developments
6.1 Iovance Biotherapeutics, Inc.- Company History
6.2 Iovance Biotherapeutics, Inc.- Latest Developments
7 Financial Analysis
7.1 Iovance Biotherapeutics, Inc.- Income Statements
7.2 Iovance Biotherapeutics, Inc.- Balance Sheet
7.3 Iovance Biotherapeutics, Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Iovance Biotherapeutics, Inc.- Direct Competitors
8.2 Iovance Biotherapeutics, Inc.- Competitor Financial Ratios comparison
8.3 Iovance Biotherapeutics, Inc.- Competitor Stock Charts Comparison
8.4 Iovance Biotherapeutics, Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!